Skip to content

IL-2 and/or therapeutic vaccines for successful treatment interruptions?

MaxCMin2 trial shows lopinavir/ritonavir superior to saquinavir/ritonavir

High pill burden means poorer adherence but adherence no role in viral load blips

Cutting though the bull: TORO at 48 weeks

Low incidence of nevirapine resistance seen in Cameroon women given drug for MTCT

Depression improves after Kaletra switch

FTC safe and effective as a hepatitis B treatment in HIV/HBV coinfected patients

US HIV doctors not taking their patients' mental health seriously say IAPAC

Tuberculosis, public health and the need for ARVs